ALLR - CIK 0001860657
Allarity Therapeutics, Inc. (ALLR) reported net income of -$11.23M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$11.23M | +54.2% |
| FY 2024 | -$24.52M | -106.0% |
| FY 2023 | -$11.90M | +25.9% |
| FY 2022 | -$16.06M | +39.7% |
| FY 2021 | -$26.65M | -302.7% |
| FY 2020 | -$6.62M | - |
Allarity Therapeutics, Inc. (ALLR) reported net income of -$11.23M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2020 and fiscal 2025, Allarity Therapeutics, Inc.'s net income declined from -$6.62M to -$11.23M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.